logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

C-MER MEDICAL (03309) spent HK$151,500 on July 23 to buy back 160,000 shares.

date
20:05 23/07/2026
avatar
GMT Eight
Xima Medical (03309) announced to repurchase 160,000 shares for 151,500 Hong Kong dollars on July 23, 2026.
C-MER MEDICAL (03309) announced on July 23, 2026, that it will spend 151,500 Hong Kong dollars to repurchase 160,000 shares.
Related Articles
China Stock
Nanchang Sanrui Intelligence Technology (301696.SZ) plans to launch a restricted stock incentive plan for the year 2026.
China Stock
Evening hot spots in A shares | CSRC speaks again! Comprehensive measures to fully maintain the stable operation of the market and enhance the resilience of the capital market.
China Stock
Walvax Biotechnology (300142.SZ): Bivalent HPV vaccine vial specifications obtain marketing authorization in Tanzania.
Nanchang Sanrui Intelligence Technology (301696.SZ) plans to launch a restricted stock incentive plan for the year 2026.
China Stock
Evening hot spots in A shares | CSRC speaks again! Comprehensive measures to fully maintain the stable operation of the market and enhance the resilience of the capital market.
China Stock
Walvax Biotechnology (300142.SZ): Bivalent HPV vaccine vial specifications obtain marketing authorization in Tanzania.
China Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.